Recombinant Human Nerve Growth Factor (Cenegermin)–Driven Corneal Wound Healing Process: An Evidence-Based Analysis

MLA

Chiara Bonzano, et al. “Recombinant Human Nerve Growth Factor (Cenegermin)–Driven Corneal Wound Healing Process: An Evidence-Based Analysis.” Frontiers in Pharmacology, vol. 12, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....73bb2d04b616c9ef50f7bde6398185e0&authtype=sso&custid=ns315887.

APA

Chiara Bonzano, Sara Olivari, Carlo Alberto Cutolo, Angelo Macrì, Daniele Sindaco, Davide Borroni, Elisabetta Bonzano, & Carlo Enrico Traverso. (2022). Recombinant Human Nerve Growth Factor (Cenegermin)–Driven Corneal Wound Healing Process: An Evidence-Based Analysis. Frontiers in Pharmacology, 12.

Chicago

Chiara Bonzano, Sara Olivari, Carlo Alberto Cutolo, Angelo Macrì, Daniele Sindaco, Davide Borroni, Elisabetta Bonzano, and Carlo Enrico Traverso. 2022. “Recombinant Human Nerve Growth Factor (Cenegermin)–Driven Corneal Wound Healing Process: An Evidence-Based Analysis.” Frontiers in Pharmacology 12 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....73bb2d04b616c9ef50f7bde6398185e0&authtype=sso&custid=ns315887.